Check out the companies that make headlines in the midday deal. Novo Nordisk – Stocks rose 4.9% after more than two years, the Food and Drug Administration said Friday. HIMS & Her Health – offering complex Wegovy and Ozempic telemedicine stocks, it fell 22.9% after the FDA announced that the Semaglutide shortage has now been “resolved”. Hims & Hers sells cheaper GLP-1 drugs by combining ingredients to customize treatments, but only allows more complex pharmacies to be sold in the event of shortages. According to the FDA’s decision, Hims and Hers will be able to use their compound facilities until May 22. Alibaba – Stocks climbed 5.7% to a fresh 52-week high after Gamestop CEO and billionaire investor Ryan Cohen raised his position in China E The Wall Street Journal reported on Thursday, – The business giant’s shares are worth approximately $1 billion. UnitedHealth – The Wall Street Journal reported that stocks fell 8.6% after insurers were under investigation by the Justice Department. The report said the survey is evaluating the record diagnostic protocol for United Health, which could lead to additional payments regarding the Medicare Advantage program. UnitedHealth said in a statement that any hint about fraud in his work was “outrageous and false”. The company’s stock price has fallen by more than 20% over the past three months as it navigates a turbulent period. Booking Holds – Stocks climbed 2% after the online travel booking platform reported fourth-quarter adjusted revenue of $41.55 per share, up from the $36.03 high expected by analysts surveyed by LSEG. Revenue also exceeded expectations at $5.47 billion, while the consensus estimate was $5.18 billion. Dropbox – Cloud Software’s stock lost about 13.8% in mixed quarterly results. Block reported that the fourth quarter’s non-GAAP gross margin was 83.1%, which matched analyst expectations. Meanwhile, the company’s adjusted revenue and revenue exceeded consensus forecasts during this period. Mercadolibre-Latin American e-commerce stocks rose 8.5% after strong fourth quarter results. The company’s earnings per share were $12.61 and revenue was $6.06 billion. Analysts expect revenue per share to be $5.88 billion, or $7.93 per share. Akamai Technologies – Stocks fell more than 18% after Akamai’s first-quarter guidance volume was weaker than expected weakness. Cloud computing companies demand adjusted revenue for the quarter between $154 and $1.59 per share, with revenue of $1 billion to $1.02 billion. InSulet – Insulet stock, which produces insulin delivery systems, accounts for 2.8% after the company requested first-quarter revenue growth of 22% to 25%, with a lower end slightly 23.1% according to the FACTSET consensus. However, Insulet’s fourth-quarter results exceeded expectations at the top and bottom lines. Block – Stocks in Block reported disappointing earnings and revenue in the fourth quarter. The fintech company has revenue of $6.03 billion, while LSEG expects revenue of $6.09 billion and revenue of $6.29 billion. Rivian Automotive – The company predicts that electric vehicle manufacturers’ shares will fall 5% after lower delivery in 2025. During this period, the company is expected to deliver between 46,000 and 51,000 units, down from 51,579 delivered last year. But revenues in the fourth quarter exceeded Wall Street estimates, and Rivian saw its first quarter total profit. – Alex Harring, Hakyung Kim, Sean Conlon, Lisa Han and Michelle Fox of CNBC contributed the report.
ABOUT US
Our news website delivers comprehensive coverage on US news, economy, politics, and world events, ensuring you stay informed on the latest developments. We provide timely and accurate news to keep you updated on the most important stories. Stay connected with us for in-depth analysis and breaking news from around the globe.
Contact us: contact@realtimeheadlines.com
© Real Times Headlines - 2024 | All Rights Reserved